Sodium-glucose Cotransporter-2 Inhibitors in Heart Failure: Mechanisms and Clinical Applications: A Machine-Generated Literature Overview

Mukesh Nandave
Passer aux renseignements sur les produits

Sodium-glucose Cotransporter-2 Inhibitors in Heart Failure: Mechanisms and Clinical Applications: A Machine-Generated Literature Overview

Mukesh Nandave
Date de sortie :
Couverture souple
Prix habituel $291.95
Prix promotionnel $291.95 Prix habituel $0.00
Vente ferme. Aucun retour ni échange.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.

Téléchargement numérique

Accès immédiat à votre bibliothèque Kobo

Livrer à

Avertissez-moi lorsque de retour en stock

Acheter maintenant et ramasser en magasin Bay & Floor

En rupture de stock

Trouver en magasin

En rupture de stock

Trouvé dans : Health, Medical Reference

Obtenez 1460 points plum  et profitez d’un rabais additionnel avec plum. En savoir plus

Afficher tous les renseignements

Aperçu

528 PAGESANGLAIS

Info promotionnelle

Overall rating: 0.0 / 5 from 0 reviews.

AI Generated Review Summary

Summary topics

Review topics: [].

Review highlights

Reviews

Q&A

  • Date de publication : Nov 16, 2025
  • Langue : anglais
  • Nombre de pages : 528
  • Éditeur : Springer Nature
  • ISBN : 9789819775705
  • Dimensions : 6.1" W x 1.0" L x 9.25" H

Dr. Mukesh Nandave is an In-charge Director of the School of Pharmaceutical Sciences, Associate Dean (Research), and head of the Department of Pharmacology and Pharmaceutical Biotechnology at Delhi Pharmaceutical Sciences and Research University, Govt. of NCT of Delhi, New Delhi, India. He has earlier served as associate professor and head of the Department of Pharmacology at NMIMS University, Mumbai (2010-2017). He has also worked as a research scientist in the Medical Affairs and Clinical Research Department of Ranbaxy Research Laboratories (currently known as Sun Pharmaceutical Industries Limited, Gurugram). Dr. Nandave earned his Ph. D. in pharmacology from AIIMS, Delhi, and received his post-doctoral training from the Division of Cardiothoracic Surgery, the Ohio State University Medical Center, Columbus, USA.

For more than 20 years, Dr. Nandave has investigated the role of nutraceuticals, herbomineral formulations, and phytoconstituents for myocardial ischemia & reperfusion injury, diabetes, obesity, and pain management. His lab received more than 3.5 crore total funding from Govt. (DBT, DST, ICMR, and AYUSH) as well as industry (Pharmazz, Dabur, Fertis India, Charak Pharma, Madhavbaug, and Sandu Pharma). He has published over 100 papers in peer-reviewed national and international journals, books, and book chapters.

Dr. Nandave has received numerous awards including the Distinguished Leadership Award of the International Academy of Cardiovascular Sciences; Prof. S. C. Lahiri Oration and G. Achari Gold Medal by the Indian Pharmacological Society; Association of Pharmaceutical Teachers of India (APTI) Young Pharmacy Teacher of the Year Award, Early Investigator Award by International Society for Heart Research, Prof. Duggirala Visweswaram & Prof. Sreemantula Satyanarayana Prize; Best Research Output of the Year for 2014-2015, 2013-2014, and 2012-2013 Award" of SVKM's NMIMS University.

Dr. Nandave is secretary general, of the International Academy of Cardiovascular Sciences (IACS)-India section and treasurer of the Society for Promotion and Research of Cardiovascular Sciences (SPARCS). He is a life member of various professional bodies including the International Society for Heart Research (ISHR), the International Academy of Cardiovascular Sciences (IACS); the Indian Pharmacological Society (IPS); the Indian Pharmaceutical Association (IPA); the Association of Physiologist and Pharmacologist of India (APPI); Association of Pharmaceutical Teachers of India (APTI); and Society for Ethnopharmacology. 

 

Articles récemment consultés